From Bench to Bedside: Bringing Therapeutic Innovation Closer to Patients

While science and technology have driven remarkable breakthroughs, they've also created unintended barriers between clinical research and care. The complexity and cost of research limit trials to only the most well-resourced hospitals. As a result, just 3% of patients and providers participate, and doctors often lack access to or the ability to act on life-changing therapies at the point of care. Oracle is closing this gap—embedding clinical trials, evidence-based insights, and innovative therapies directly into electronic health records. The vision: every hospital research-ready, every patient encounter fueling discovery, and therapeutic innovation reaching patients where and when it matters most.

Featuring:

·       Moderator: Raj Modi, Senior Director, Global Customer Centre of Excellence, Life Sciences, Oracle

·       Panelist: Maria Clark, Market Development Associate Greenphire-Suvoda, Patient Advocate for Cystic Fibrosis Foundation

·       Panelist: Christopher P. Boone, Ph. D., Group Vice President, Research Services, Health & Life Sciences, Oracle

Listen as they discuss:

o   Why therapeutic innovation often stops short of the point of care—and what it takes to close that gap

o   How aggregating genomic, clinical, and real-world data at scale — safely and securely — is key to unlocking this future and driving personalized medicine

o   How embedding trials, insights, and therapies into the EHR will reshape access to cutting-edge treatments, lowering cost, and improving outcomes

o   How the industry is approaching this shift—and what progress is already underway

Notable quotes:

"Because of these CFTR modulators, patients like myself are living longer than ever before. I am only 23 years old and when I was born my life expectancy was early 20's." – Maria Clark